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Cronobacter sakazakii (C. sakazakii), formerly Enterobacter sakazakii, is an emerging pathogen associated
with the ingestion of contaminated reconstituted formula that causes serious illnesses such as bacteremia,
septicemia, necrotizing enterocolitis, meningitis and death in low-birth-weight preterm neonatal infants.
The objective of this study was to develop an animal model for human neonatal C. sakazakii infections.
We acquired timed-pregnant ICR mice and allowed them to give birth naturally. On postnatal day 3.5,
each pup was administered orally a total dose of approximately 10
7 CFU C. sakazakii strain 3439. Mice
were observed twice daily for morbidity and mortality. At postnatal day 10.5, the remaining pups were
euthanized, and brain, liver, and cecum were excised and analyzed for the presence of C. sakazakii. C.
sakazakii was isolated from cecum and other tissues in inoculated mice. In the tissues of C. sakazakii
infected mice, meningitis and gliosis were detected in brain. In this study, we confirmed the neonatal ICR
mice may be used a very effective animal model for human neonatal C. sakazakii infections.
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Neonatal infections believed to have been caused by
Cronobacter sakazakii (C. sakazakii), formerly Enterobacter
sakazakii (Iversen et al, 2008), were first reported by Urmenyi
and Franklin (1961). Cronobacter are motile peritrichous,
Gram-negative, rod-shaped, non-spore-forming bacteria
(Iversen et al, 2004). Cronobacter is recognized worldwide
as an emerging foodborne pathogen (Drudy et al, 2006).
Cronobacter is distributed and frequently contaminated in
the environment, plant materials, powdered infant formulas,
cereal foods, fermented beverages, fruits, and vegetables
(Drudy et al, 2006). In particular, contamination on powdered
infant formula occurs more easily because it is a nonsterilized
product (Beuchat et al, 2009). C. sakazakii infections are an
important cause of life-threatening meningitis, septicemia, and
necrotizing enterocolitis in infants and neonates (Nazarowec-
White and Farber, 1997; Lai, 2001; Drudy et al, 2006).
Premature and low-birth-weight infants and those aged <28
days are considered to be more at risk than are older infants
(Bar-Oz et al, 2001). To examine C. sakazakii infection, human
studies are unethical because mortality is a possible outcome
for suitable individuals (Richardson et al, 2009). Animal
surrogate studies are essential for extrapolation of C. sakazakii
infection in humans. The design of an animal model for C.
sakazakii infection is fundamental in gaining knowledge of
why premature and immunocompromised human infants are
at greater risk of infection. Furthermore, an animal model
will allow us to test different strains of C. sakazakii for virulence
(Richardson et al, 2009). The objective of this study was to
evaluate the usability of neonatal ICR mice as an animal
model for human C. sakazakii  infections.
We acquired specific pathogen-free (SPF) timed-pregnant
ICR mice at gestation day 15 from Samtako (Osan, Korea).
Dams were acclimatized and kept in an isolated SPF barrier
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room with regulated temperature (23±1°C), humidity (50±5%)
and light/dark cycle (12/12 hours). The animals were fed
sterilized pellet diet by 2 M rad radiation (Purina, Seongnam,
Korea) and sterilized water ad libitum. Dams were allowed
to give birth naturally. Litters averaged 11 pups were divided
with 2 groups (infection and control) and kept in an opaque,
polypropylene cage under a small animal isolator. Neonates
were treated orally by gavage on postnatal day 3.5 by using
a 24 gauge, 3.175 stainless steel animal feeding tube (Popper
& Sons, New York, USA) attached to a 1 mL syringe. In the
other study, the oral infectious dose has been approximated
to range from 10
3 (Iversen and Forsythe, 2003) to ≥10
8 CFU
(Pagotto et al, 2003). In this study, 3.5 day-old mice pups
(n=11) inoculated orally with 10
7 CFU of C. sakazakii strain
3439 (isolated from commercially manufactured powdered
infant formula) in 0.1 mL of hydrated infant formula with
feeding tube. Control mice (n=11) received saline through
the same route. Mice were observed twice daily for morbidity
and mortality. We defined morbidity as noticeable lethargy
and change of skin color from pink to blue or grey. At postnatal
day 10.5, the remaining pups were euthanized, and brain,
liver, small intestine and cecum were excised and cultured
for  C. sakazakii from the neonates. Also, the tissues were
submitted to histopathological analysis. All studies were
performed in accordance with the Guide for Animal
Experimentation by Wonkwang University and approved by
the Institutional Animal Care and Use Committee of
Wonkwang University. All efforts were made to minimize
pain or discomfort of animals used.
Each organ was aseptically taken from each mouse, mixed
with 100 mL of Enterobacteriaceae enrichment (EE) broth
(BD/Difco, Sparks, USA), and pummeled in a stomacher
(Seward Medical, London, UK) at 260 rpm for 1 min. The
mixtures were incubated at 37
oC overnight for enrichment
of C. sakazakii in tissues. After incubation, the EE broth was
streaked onto violet red bile glucose (VRBG) agar (BD/Difco)
and incubated at 37
oC for 16-18 hours. Cells from presumptive
C. sakazakii colonies were streaked on tryptic soy agar (BD/
Difco) and incubated at 25
oC for 16-18 hours. Cells from
yellow-pigmented colonies were subjected to confirmation
using the API 20E kit. Simultaneously, 16s rRNA gene
sequencing of cells from presumptive C. sakazakii colonies
was performed by Macrogen (Seoul, Korea; http://www.
macrogen. com). The 16s rRNA gene sequences were analyzed
by an NCBI BLAST search (http://www. ncbi. nlm.nih.gov/
blast/Blast.cgi) for identification of C. sakazakii.
For histopatholocal analysis, the exercised tissues were fixed
in 10% buffered formalin, routinely processed, and embedded
in paraffin. Then, 4 µm sections were cut on microtome
(Thermo Shandon, Cheshire, UK) and stained with hematoxylin
and eosin.
In control mice, there were no dead animals during the
experiment period. However, in mice of the infection group,
6 cases were dead at 3 days post-inoculation of C. sakazakii.
Seven days after treating 3.5-day-old neonatal mice by oral
gavage, C. sakazakii isolated from liver (3 cases in 5 survival
pups), brain (2 cases in 5 survival pups), and cecum (5 cases
in 5 survival pups) of C. sakazakii infected mice. In control
mice, there were no histopathological changes. However,
histopathological findings of the C. sakazakii-infected mice
were meningitis and gliosis, and inflammatory cell infiltration
in the cerebrum (3 cases in 5 survival pups) (Figure 1), and
inflammatory cell infiltration and cellular degeneration in the
liver (3 cases in 5 survival pups) (Figure 2), and inflammatory
cell infiltration and cellular degeneration in the cecum (5
cases in 5 survival pups) (Figure 3).
C. sakazakii has been isolated from a wide range of
environmental sources and foods of animal and plant origins,
however, outbreaks of its infections have been linked only
to powdered infant formula (Beuchat et al, 2009). Developing
animal model as a surrogate for C. sakazakii infection  in
Figure 1. Histopathological findings of the cerebrum of
Cronobacter sakazakii-infected mice. A: gliosis (black arrows),
bar=100 µm. B: meningitis (black arrows), bar=50 µm. Hematoxylin-
eosin stain.Cronobacter sakazakii infection of neonatal mice 61
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premature infants is an important step forward, enabling
subsequent research into understanding the mechanisms of
infection, morbidity, prevention and treatment (Richardson
et al, 2009). C. sakazakii is an opportunistic pathogen causing
invasive infections (meningitis, sepsis, and necrotizing
enterocolitis) with high death rates (40-80%), primarily in
newborns (Bar-Oz et al, 2001; Iversen and Forsythe, 2003).
In this study, we identified neonatal ICR mice as an animal
model of C. sakazakii infection  in premature infants. We
observed  C. sakazakii infection-related deaths in infected
neonatal mice. Also, C. sakazakii isolated from liver, brain,
and cecum of infected survival mice. In the C. sakazakii-
infected mice, histopathological changes were detected in
brain, liver and cecum. Our results indicate that C. sakazakii
could be colonized and replication in ICR mice. Our results
also show that C. sakazakii can induce meningitis and gliosis
in neonatal mice. This is important because meningitis and
other neurological squels are known to occur in human infants
because of C. sakazakii infection. Mice are the most commonly
used vertebrate species, popular because of their availability,
size, low cost, ease of handling, and fast reproduction rate
(Zak, 1999). ICR mice are the most popular strain of mice
(Willis-Owen and Flint, 2006). In this study, we confirmed
the neonatal ICR mice may be used a very effective animal
model for human neonatal C.  sakazakii  infections. In
conclusion, these results demonstrate that the neonatal ICR
mice model may be used a very effective animal model for
human neonatal C. sakazakii infections.
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